![Vinay Shah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vinay Shah
Direttore Finanziario/CFO presso VIRPAX PHARMACEUTICALS, INC.
Patrimonio netto: 23 664 $ in data 31/12/2023
Provenienza dei contatti di primo grado di Vinay Shah
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 29 | |
Public Company | Biotechnology | 21 | |
Public Company | Pharmaceuticals: Major | 11 | |
Aravive Biologics, Inc.
![]() Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Ranchi University
1
| College/University | Other Consumer Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Vinay Shah tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
HERON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO General Counsel | |
THE COOPER COMPANIES, INC. | Medical Specialties | Director of Finance/CFO Treasurer | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Product Development LLC
![]() Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Chairman Director/Board Member Sales & Marketing Corporate Officer/Principal | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
NextWave Pharmaceuticals, Inc.
![]() NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
Selexagen Therapeutics, Inc. | Founder Founder | ||
Ignyta Operating, Inc.
![]() Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SCILEX Pharmaceuticals, Inc.
![]() SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
Stanford University | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | General Counsel General Counsel | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
St. Joseph's University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
University of Wisconsin | College/University | Doctorate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
University of Illinois | College/University | Graduate Degree Undergraduate Degree | |
The University of North Carolina at Chapel Hill | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Ardea Biosciences, Inc.
![]() Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
RELYPSA INC | Pharmaceuticals: Major | Founder Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
PPD, INC. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal Corporate Officer/Principal | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
IGNYTA INC | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin | |
Star Therapeutics, Inc.
![]() Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Meryx, Inc.
![]() Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Fordham University School of Law | College/University | Graduate Degree Graduate Degree | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
JIYA ACQUISITION CORP. | Financial Conglomerates | Chairman Chief Executive Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 47 |
Regno Unito | 3 |
Svizzera | 2 |
Settori
Health Technology | 30 |
Consumer Services | 13 |
Finance | 5 |
Commercial Services | 4 |
Posizioni
Director/Board Member | 411 |
Corporate Officer/Principal | 187 |
Independent Dir/Board Member | 148 |
Undergraduate Degree | 57 |
Chairman | 56 |
Contatti più connessi
Insiders | |
---|---|
Carl Gordon | 59 |
Srini Akkaraju Akkaraju | 55 |
Luke Evnin | 42 |
Fred Eshelman | 34 |
Gary Pace | 32 |
Fred Middleton | 30 |
Jay Shepard | 30 |
Laura Brege | 27 |
Scott Braunstein | 26 |
Paul Hastings | 25 |
Mohammed Malik | 24 |
Robert Hoffman | 22 |
Eric Floyd | 20 |
John Hohneker | 19 |
Rekha Hemrajani | 17 |
- Borsa valori
- Insiders
- Vinay Shah
- Connessioni Società